Show simple item record

dc.contributor.authorJameson, TSO
dc.contributor.authorCaldow, MK
dc.contributor.authorStephens, F
dc.contributor.authorDenehy, L
dc.contributor.authorLynch, GS
dc.contributor.authorKoopman, R
dc.contributor.authorKrajcova, A
dc.contributor.authorUrban, T
dc.contributor.authorBerney, S
dc.contributor.authorDuska, F
dc.contributor.authorPuthucheary, Z
dc.date.accessioned2023-11-21T11:44:44Z
dc.date.available2023-09-26
dc.date.available2023-11-21T11:44:44Z
dc.date.issued2023-11-06
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/92101
dc.description.abstractBACKGROUND: Critically ill patients suffer from acute muscle wasting, which is associated with significant physical functional impairment. We describe data from nested muscle biopsy studies from two trials of functional electrical stimulation (FES) that did not shown improvements in physical function. METHODS: Primary cohort: single-centre randomized controlled trial. Additional healthy volunteer data from patients undergoing elective hip arthroplasty. Validation cohort: Four-centre randomized controlled trial. INTERVENTION: FES cycling for 60-90min/day. ANALYSES: Skeletal muscle mRNA expression of 223 genes underwent hierarchal clustering for targeted analysis and validation. RESULTS: Positively enriched pathways between healthy volunteers and ICU participants were "stress response", "response to stimuli" and "protein metabolism", in keeping with published data. Positively enriched pathways between admission and day 7 ICU participants were "FOXO-mediated transcription" (admission = 0.48 ± 0.94, day 7 = - 0.47 ± 1.04 mean log2 fold change; P = 0.042), "Fatty acid metabolism" (admission = 0.50 ± 0.67, day 7 = 0.07 ± 1.65 mean log2 fold change; P = 0.042) and "Interleukin-1 processing" (admission = 0.88 ± 0.50, day 7 = 0.97 ± 0.76 mean log2 fold change; P = 0.054). Muscle mRNA expression of UCP3 (P = 0.030) and DGKD (P = 0.040) decreased in both cohorts with no between group differences. Changes in IL-18 were not observed in the validation cohort (P = 0.268). Targeted analyses related to intramuscular mitochondrial substrate oxidation, fatty acid oxidation and intramuscular inflammation showed PPARγ-C1α; (P < 0.001), SLC25A20 (P = 0.017) and UCP3 (P < 0.001) decreased between admission and day 7 in both arms. LPIN-1 (P < 0.001) and SPT1 (P = 0.044) decreased between admission and day 7. IL-18 (P = 0.011) and TNFRSF12A (P = 0.009) increased in both arms between admission and day 7. IL-1β (P = 0.007), its receptor IL-1R1 (P = 0.005) and IL-6R (P = 0.001) decreased in both arms between admission and day 7. No between group differences were seen in any of these (all p > 0.05). CONCLUSIONS: Intramuscular inflammation and altered substrate utilization are persistent in skeletal muscle during first week of critical illness and are not improved by the application of Functional Electrical Stimulation-assisted exercise. Future trials of exercise to prevent muscle wasting and physical impairment are unlikely to be successful unless these processes are addressed by other means than exercise alone.en_US
dc.format.extent428 - ?
dc.languageeng
dc.relation.ispartofCrit Care
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectCritical illnessen_US
dc.subjectExerciseen_US
dc.subjectGene expressionen_US
dc.subjectMuscle wastingen_US
dc.subjectRehabilitationen_US
dc.subjectHumansen_US
dc.subjectCritical Illnessen_US
dc.subjectInterleukin-18en_US
dc.subjectIntensive Care Unitsen_US
dc.subjectMuscular Atrophyen_US
dc.subjectElectric Stimulationen_US
dc.subjectFatty Acidsen_US
dc.subjectRNA, Messengeren_US
dc.subjectMembrane Transport Proteinsen_US
dc.titleInflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patients.en_US
dc.typeArticleen_US
dc.identifier.doi10.1186/s13054-023-04664-7
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37932834en_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
pubs.volume27en_US
dcterms.dateAccepted2023-09-26


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States